Skip to main content
Log in

The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Hirschsprung's disease (HD) can be associated with the development of neuroendocrine tumours such as medullary thyroid carcinoma (MTC). The RET proto-oncogene is the major gene responsible for both HD and MTC. Mutations in exon 10 (codons 609, 611, 618, 620) were found in patients with co-occurrence of HD and MTC. The aim of the study was to screen the MTC risk in patients with HD. The prospective and retrospective genetic analyses comprised 56 HD patients (41 males, 15 females, aged 0–47). The prospective subgroup of patients consisted of 34 patients (25 boys, 9 girls) operated on between June 2003 and December 2005. The retrospective subgroup comprised 22 patients (16 boys, 6 girls) of 194 patients who were operated on between December 1979 and May 2003, non-systematically chosen preferably for total colonic aganglionosis (TCA). DNAs were isolated from blood and resected segments of aganglionic bowel. The HD patients and nine available family members (2 HD) were tested for RET mutations in exons 10, 11, 13, 14, 15 and 16. Direct double-stranded fluorescent sequencing revealed typical germline heterozygous MTC risk RET mutations in 3/56 (5.4%) female HD patients: Cys609Tyr, Cys620Arg (both exon 10) and Tyr791Phe (exon 13). Two of these patients had TCA and one patient had classical type of HD. One TCA patient developed clinical stage of MTC and underwent total thyroidectomy (TTE). The other two RET positive HD patients (aged 7 and 25 years) are screened for calcitonin level and they are without TTE till now. Two family members (mothers of TCA patients) with detected RET mutation underwent prophylactic TTE with MTC finding. Results showed the benefit of systematic RET mutation screening in HD patients in order to identify the risk of MTC in preclinical stage of the disease in patients with HD and their family members. We recommend to investigate not only exon 10 but also exon 13.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

MTC:

Medullary, thyroid carcinoma

HD:

Hirschsprung's disease

RET:

Rearranged during transfection

TCA:

Total colonic aganglionosis

TTE:

Total thyroidectomy

References

  1. Coran AG (2004) Hirschsprung's disease. In: Neill JA Jr, Grosfeld JL, Fonkalsrud EW, Coran AG, Caldamone AA (eds) Principles of pediatric surgery. Mosby, St. Louis, pp 573–586

    Google Scholar 

  2. Puri P (2000) Hirschsprung's disease: clinical generalities. In: Hollschneider AM, Puri P (eds) Hirschsprung's disease and allied disorders. Harwood academic publishers, Amsterdam, pp 129–136

    Google Scholar 

  3. Parisi MA, Kapur RP (2000) Genetics of Hirschsprung disease. Curr Opin Pediatr 12:610–617

    Article  PubMed  CAS  Google Scholar 

  4. Lantieri F, Griseri P, Ceccherini I (2006) Molecular mechanisms of RET-induced Hirschsprung pathogenesis. Ann Med 38:11–19

    Article  PubMed  CAS  Google Scholar 

  5. Edery P, Lyonnet S, Mulligan L, Pelet A, Dow E, Abel L, Holder S, Nihoul-Fekete C, Ponder BA, Munnich A (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367:378–380

    Article  PubMed  CAS  Google Scholar 

  6. Hansford JR, Mulligan LM (2000) Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 37:817–827

    Article  PubMed  CAS  Google Scholar 

  7. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671

    Article  PubMed  CAS  Google Scholar 

  8. Jindrichova S, Vlcek P, Bendlova B (2004) Genetic causes of the thyroid carcinomas. Cas Lek Cesk 143:664–668

    PubMed  CAS  Google Scholar 

  9. Arighi E, Popsueva A, Innocenti DD, Borrello MG, Carniti C, Perala NM, Pierotti MA, Sariola H (2004) Biological effects of the dual phenotypic Janus mutation of ret co-segregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. Mol Endocrinol 18:1004–1017

    Article  PubMed  CAS  Google Scholar 

  10. Pelet A, Geneste O, Edery P, Pasini A, Chappuis S, Atti T, Munnich A, Lenoir G, Lyonnet S, Billaud M (1998) Various mechanisms cause RET-mediated signalling defects in Hirschsprung's disease. J Clin Invest 101:1415–1423

    Article  PubMed  CAS  Google Scholar 

  11. Inoue K, Shimotake T, Inoue K, Tokiwa K, Iwai N (1999) Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease. J Pediatr Surg 34:1552–1554

    Article  PubMed  CAS  Google Scholar 

  12. Dvořáková S, Dvořáková K, Malíková M, Škába R, Vlček P, Bendlová B (2005) A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease. J Pediatr Surg 40:E1–E6

    Article  PubMed  Google Scholar 

  13. Romeo G, Ceccherini I, Celli J, Priolo M, Betsos N, Bonardi G, Seri M, Yin L, Lerone M, Jasonni V, Martucciello G (1998) Association of multiple endocrine neoplasia type 2 and Hirschsprung disease. J Intern Med 243:515–520

    Article  PubMed  CAS  Google Scholar 

  14. Sijmons RH, Hofstra RMW, Wijburg FA, Links TP, Zwierstra RP, Vermey A, Aronson DC, Tan-Sindhunata G, Brouwers-Smalbraak GJ, Maas SM, Buys CH (1998) Oncological implications of RET gene mutations in Hirschsprung's disease. Gut 43:542–547

    Article  PubMed  CAS  Google Scholar 

  15. Decker RA, Peacock ML, Watson P (1998) Hirschsprung disease in MEN2A: increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation. Hum Mol Genet 7:129–134

    Article  PubMed  CAS  Google Scholar 

  16. Pasini B, Rossi R, Ambrosio MR, Zatelli MC, Gullo M, Gobbo M, Collini P, Aiello A, Pansini G, Trasforini G, degli Uberti EC (2002) RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. Surgery 131:373–381

    Article  PubMed  Google Scholar 

  17. Borrego S, Eng C, Sanchez B, Saez ME, Navarro E, Antinolo G (1998) Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab 83:3361–3364

    Article  PubMed  CAS  Google Scholar 

  18. Škába R, Dudorkinová D, Lojda Zd, Dvořáková H, Pýcha K, Kabelka M (1994) Kasai's rectoplasty in the treatment of Hirschsprung's disease and another types of colorectal dysganglionosis in children. Analysis of 94 cases. Pediatr Surg Int 9:503–506

    Google Scholar 

  19. Sasaki Y, Shimotake T, Go S, Iwai N (2001) Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease. Eur J Surg 167:467–469

    Article  PubMed  CAS  Google Scholar 

  20. Pakarinen MP, Rintala RJ, Koivusalo A, Heikkinen M, Lindahl H, Pukkala E (2005) Increased incidence of medullary thyroid carcinoma in patients treated for Hirschsprung's disease. J Pediatr Surg 40:1532–1534

    Article  PubMed  Google Scholar 

  21. Fitze G, Schierz M, Bredow J, Saeger HD, Roesner D, Schackert HK (2002) Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations. Ann Surg 236:570–575

    Article  PubMed  Google Scholar 

  22. Gimm O, Niederle BE, Weber T, Bockhorn M, Ukkat J, Brauckhoff M, Thanh PN, Frilling A, Klar E, Niederle B, Dralle H (2002) RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome? Surgery 132:952–959

    Article  PubMed  Google Scholar 

  23. Kim SM, Oh JT, Cho SH (2006) Hirschsprung's disease in Korea clinical experience of 233 cases in single tertiary medical center. Jpn Soc Pediatr Surg 43:385

    Google Scholar 

Download references

Acknowledgments

We would like to thank all the subjects who participated in this study. This work was supported by IGA MH CR NR/7806-3 and GACR 301/06/P425. The Family 1 with Cys609Tyr mutation was published previously as a case report in the article of Dvořáková et al. [12].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Richard Škába.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Škába, R., Dvořáková, Š., Václavíková, E. et al. The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease. Pediatr Surg Int 22, 991–995 (2006). https://doi.org/10.1007/s00383-006-1785-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-006-1785-6

Keywords

Navigation